60. Which of the following medications is exempt from the requirements of the Drug Supply Chain Security Act (DSCSA) because it is indicated for use only in animals?
Answer: D
Enrofloxacin tablets are exempt from the requirements of the Drug Supply Chain Security Act (DSCSA) because they are indicated for use only in animals.
Enrofloxacin tablets are specifically approved for veterinary use, meaning they do not fall under the regulatory requirements imposed by the DSCSA, which primarily applies to human medications.
A) Cephalexin capsules
Cephalexin capsules are indicated for human use to treat bacterial infections and therefore do not qualify for exemption under the DSCSA. This medication is part of the human drug supply chain and is subject to all related regulations.
B) Amoxicillin capsules
Amoxicillin capsules are also intended for human use, particularly in treating various infections. As a human medication, it is not exempt from the DSCSA requirements, making this option incorrect.
C) Oseltamivir tablets
Oseltamivir tablets, commonly known as Tamiflu, are prescribed for treating influenza in humans. Since they are not exclusively indicated for animal use, they do not meet the criteria for exemption from the DSCSA.
D) Enrofloxacin tablets
Enrofloxacin tablets are solely indicated for veterinary use, specifically for treating infections in animals. This distinction allows them to be exempt from the DSCSA requirements, confirming this option as correct.
Conclusion
Enrofloxacin tablets are the only medication listed that is specifically indicated for use in animals, thereby qualifying for exemption from the DSCSA. The other options, being human medications, must adhere to the regulations outlined in the Act, highlighting the unique status of enrofloxacin in this context.